MedTrace Logo

Origin of CEC in Patients After Allo-HSCT

NCT04038827 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2020-07-08

No results posted yet for this study

Summary

We believe that CEC, besides coming from cells shedding from patient vasculature, could partly belong to donor, originating from the cellular graft.

Conditions

  • Graft Versus Host Disease, Acute
  • Endothelial Dysfunction
  • Immune Tolerance

Interventions

DIAGNOSTIC_TEST

D-CEC counting

By means of preliminary bulk separation step with the CellSearch system, single CEC will be sorted

Sponsors & Collaborators

  • Università degli Studi di Brescia

    collaborator OTHER

  • University of Turin, Italy

    collaborator OTHER

  • Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

    lead OTHER

Principal Investigators

  • Camillo Almici, MD · ASST Spedali Civili di Brescia

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-27
Primary Completion
2020-01-31
Completion
2020-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04038827 on ClinicalTrials.gov